Ad
related to: mifepristone cost in kenya
Search results
Results From The WOW.Com Content Network
Abortion in Kenya is regulated by Article 26(4) of the Constitution of Kenya (2010), which states that: . Abortion is not permitted unless, in the opinion of a trained health professional, there is need for emergency treatment, or the life or health of the mother is in danger, or if permitted by any other written law.
€4,21 – €4,73 (Mifepristone) 62% (2012) † Free for women under 21 and in cases of rape at Youth Friendly Health Centres [93] Montenegro: Europe: Possibly due to small population [2] Morocco: Africa [94] Mozambique: Africa: Myanmar: Asia: None: Under Ks1,000: Sale was stopped by authorities during holidays [95] [96] Nepal: Asia (LNG only ...
Chinese organizations tried to purchase mifepristone from Roussel Uclaf, which refused to sell it to them, so in 1992 China began its own domestic production of mifepristone. In 2000, the cost of medication abortion with mifepristone was higher than surgical abortion and the percentage of medication abortions varied greatly, ranging from 30% to ...
For premium support please call: 800-290-4726 more ways to reach us
The costs to the healthcare systems of PAC are greater than the costs of safe abortion. [1] Stigma about abortion and unawareness of PAC among medical workers contribute to low availability. As of 2018, PAC is offered by fewer than 10% of primary care facilities in Kenya, Namibia, Rwanda, Tanzania and Uganda. [39]
The mifepristone-misoprostol combination is, by far, the most recommended drug regimen for medical abortions, but other drug combinations are available. Misoprostol alone, without mifepristone, may be used in some circumstances for medical abortion, and has even been demonstrated to be successful in the second trimester. [37]
In 2000, GenBioPro's generic version of mifepristone was approved for medication abortion, as part of a two-drug regimen in combination with misoprostol. In 2023, GenBioPro sued the FDA to obtain a legal judgement confirming that mifepristone could continue to be sold, in spite of anti-abortion laws passed in some states.
In 1997, Gideon Richter withdrew from efforts to manufacture mifepristone in the United States following opposition from pro-life groups, which led to Danco filing a breach of contract lawsuit. [ 6 ] On September 28, 2000, Danco Laboratories received approval to distribute mifepristone (under the Mifeprex brand name) from the US Food and Drug ...